1. Academic Validation
  2. Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules

Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules

  • Int J Mol Sci. 2021 Jun 27;22(13):6899. doi: 10.3390/ijms22136899.
Kyung-Ran Park 1 Joon Yeop Lee 2 Myounglae Cho 2 Jin Tae Hong 3 Hyung-Mun Yun 1
Affiliations

Affiliations

  • 1 Department of Oral and Maxillofacial Pathology, School of Dentistry, Kyung Hee University, Seoul 02447, Korea.
  • 2 National Institute for Korean Medicine Development, Gyeongsan 38540, Korea.
  • 3 College of Pharmacy and Medical Research Center, Chungbuk National University, Chungbuk 28160, Korea.
Abstract

Paeonia suffruticosa is a magnificent and long-lived woody plant that has traditionally been used to treat various diseases including inflammatory, neurological, Cancer, and cardiovascular diseases. In the present study, we demonstrated the biological mechanisms of paeonoside (PASI) isolated from the dried roots of P. suffruticosa in pre-osteoblasts. Herein, we found that PASI has no cytotoxic effects on pre-osteoblasts. Migration assay showed that PASI promoted wound healing and transmigration in osteoblast differentiation. PASI increased early osteoblast differentiation and mineralized nodule formation. In addition, PASI enhanced the expression of Wnt3a and Bone Morphogenetic Protein 2 (BMP2) and activated their downstream molecules, Smad1/5/8 and β-catenin, leading to increases in runt-related transcription factor 2 (RUNX2) expression during osteoblast differentiation. Furthermore, PASI-mediated osteoblast differentiation was attenuated by inhibiting the BMP2 and Wnt3a pathways, which was accompanied by reduction in the expression of RUNX2 in the nucleus. Taken together, our findings provide evidence that PASI enhances osteoblast differentiation and mineralized nodules by regulating RUNX2 expression through the BMP2 and Wnt3a pathways, suggesting a potential role for PASI targeting osteoblasts to treat bone diseases including osteoporosis and periodontitis.

Keywords

BMP2; RUNX2; Wnt3a; bone mineralization; osteoblast differentiation; paeonoside.

Figures
Products